Episode 38: Q3 earnings are relatively weak but the revised estimates have been dumbed down to only around 4.5%…so a “surprise” beat expectations is probably cooked into the books. Expect earnings growth to exceed 6%…which would be down from last quarter’s growth of 7.5% and way down from early estimates of double digit growth.
In Part I we discuss Pharma and High Tech earning results.
Subscribe to the Wealthsteading Podcast:
via STITCHER: http://www.stitcher.com/s?fid=53115&refid=stpr
Hosted by John Pugliano. The Wealthsteading Podcast teaches 10 wealth building principles to help investors build wealth and attain personal freedom.
For more information visit us at: www.wealthsteading.com or www.investablewealth.com
Copyright © 2014 Investable Wealth, LLC. All rights reserved. This podcast is for informational purposes only and is not intended to be a solicitation, offering advice or recommendation of any security. This podcast does not intend to provide investment, tax or legal advice. The content is strictly the observations and opinions of Investable Wealth, LLC. The information in this podcast is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Investable Wealth, LLC is an investment advisory firm licensed in the State of Utah.